[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100541724":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":22,"locations":27,"responsibleParty":41,"collaborators":10,"id":43,"slug":10,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":44,"sex":50,"minAge":51,"maxAge":10,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":10,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"European Institute of Oncology","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"image-guided thermal ablation",null,"image-guided thermal ablation in patients with diagnosis of micropapillary thyroid carcinoma",[13],"Procedure: image-guided thermal ablation",[15],{"type":16,"name":9,"description":11,"armGroupLabels":17,"otherNames":10},"PROCEDURE",[9],[19],{"name":20,"affiliation":5,"role":21},"Giovanni Mauri","PRINCIPAL_INVESTIGATOR",[23],{"name":20,"role":24,"phone":25,"phoneExt":10,"email":26},"CONTACT","+390294372691","giovanni.mauri@ieo.it",[28],{"facility":5,"status":29,"city":30,"state":10,"zip":10,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Milan","Italy","IT",{"type":34,"coordinates":35},"Point",[36,37],9.18951,45.46427,{"lat":37,"lon":36},[40],{"name":20,"role":24,"phone":10,"phoneExt":10,"email":10},{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100541724",false,"NCT06333587","Minimally Invasive Treatments of the Thyroid","Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma","MIPA-MITT","Inclusion Criteria:\n\n* Patients \\> 18years\n* Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT.\n* Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.\n* Patients must be accessible for follow-up\n\nExclusion Criteria:\n\n* Tumors \\> 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders\n* Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study","ALL","18 Years",{"count":53,"type":54},270,"ESTIMATED","OBSERVATIONAL","This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)",[58],"Papillary Thyroid Microcarcinoma","2024-03-21",{"date":61,"type":62},"2024-03-27","ACTUAL",{"date":64,"type":62},"2022-10-10",{"date":66,"type":54},"2035-12-31",{"name":5,"class":6},1]